238 related articles for article (PubMed ID: 28078633)
1. Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data.
Biétry FA; Pfeil AM; Reich O; Schwenkglenks M; Meier CR
CNS Drugs; 2017 Mar; 31(3):245-251. PubMed ID: 28078633
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
Imfeld P; Bodmer M; Jick SS; Meier CR
Drug Saf; 2015 Oct; 38(10):909-19. PubMed ID: 26123874
[TBL] [Abstract][Full Text] [Related]
3. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study.
Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
Acta Psychiatr Scand; 2018 Aug; 138(2):91-100. PubMed ID: 29851063
[TBL] [Abstract][Full Text] [Related]
4. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
[TBL] [Abstract][Full Text] [Related]
5. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
[TBL] [Abstract][Full Text] [Related]
6. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H
J Am Med Dir Assoc; 2017 Jan; 18(1):87.e15-87.e21. PubMed ID: 27847263
[TBL] [Abstract][Full Text] [Related]
7. The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study.
Chen SJ; Yeh CM; Chao TF; Liu CJ; Wang KL; Chen TJ; Chou P; Wang FD
Sleep; 2015 Jul; 38(7):1045-50. PubMed ID: 25669186
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepine use and risk of Alzheimer's disease: case-control study.
Billioti de Gage S; Moride Y; Ducruet T; Kurth T; Verdoux H; Tournier M; Pariente A; Bégaud B
BMJ; 2014 Sep; 349():g5205. PubMed ID: 25208536
[TBL] [Abstract][Full Text] [Related]
9. Statin use and risk of cholecystectomy - A case-control analysis using Swiss claims data.
Biétry FA; Reich O; Schwenkglenks M; Meier CR
Expert Opin Drug Saf; 2016 Dec; 15(12):1577-1582. PubMed ID: 27677561
[TBL] [Abstract][Full Text] [Related]
10. Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion.
Sheehy O; Zhao JP; Bérard A
JAMA Psychiatry; 2019 Sep; 76(9):948-957. PubMed ID: 31090881
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
Gray SL; Dublin S; Yu O; Walker R; Anderson M; Hubbard RA; Crane PK; Larson EB
BMJ; 2016 Feb; 352():i90. PubMed ID: 26837813
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
Imfeld P; Bodmer M; Jick SS; Meier CR
Drug Saf; 2018 Dec; 41(12):1387-1396. PubMed ID: 30146658
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study.
Tamimi I; Ojea T; Sanchez-Siles JM; Rojas F; Martin I; Gormaz I; Perez A; Dawid-Milner MS; Mendez L; Tamimi F
J Bone Miner Res; 2012 Jul; 27(7):1518-27. PubMed ID: 22467182
[TBL] [Abstract][Full Text] [Related]
14. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
[TBL] [Abstract][Full Text] [Related]
15. Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data.
Becker C; Schwenkglenks M; Frueh M; Reich O; Meier CR
Eur J Clin Pharmacol; 2020 Sep; 76(9):1329-1335. PubMed ID: 32504184
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and risk of early-onset Alzheimer's disease: a population-based case-control study.
Kadohara K; Sato I; Kawakami K
Eur J Neurol; 2017 Jul; 24(7):944-949. PubMed ID: 28503814
[TBL] [Abstract][Full Text] [Related]
17. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
18. Predictors of adherence among Alzheimer's disease patients receiving oral therapy.
Borah B; Sacco P; Zarotsky V
Curr Med Res Opin; 2010 Aug; 26(8):1957-65. PubMed ID: 20569067
[TBL] [Abstract][Full Text] [Related]
19. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
[TBL] [Abstract][Full Text] [Related]
20. Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.
Gomm W; von Holt K; Thomé F; Broich K; Maier W; Weckbecker K; Fink A; Doblhammer G; Haenisch B
J Alzheimers Dis; 2016 Sep; 54(2):801-8. PubMed ID: 27567804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
